Pfizer Global Medical Grants: PARP-Inhibitors in Prostate Cancer – Medical Education Competitive Grant Program

Projects that will be considered for support under this grant program will focus on increasing the understanding of PARP inhibitors and the future of their use in the treatment of advanced prostate cancer. Topics of interest include Mechanisms of Action of PARP inhibitors, selection of appropriate patients, biomarker testing process, analytical platforms and result interpretation to inform decision-making, and management of patients treated with PARP inhibitors.

Funding & Duration

Funding of up to US $150,000 (approx. AUD $218,000) will be considered, for a maximum period of two years.


Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.

Comments are closed.